posted on 2021-08-26, 06:20authored byPaola Villanueva
<p></p><p>Visualise Your Thesis video entry</p><p>Title: Vaccine
safety in numbers</p><p><br></p><p>We
know vaccines protect us, but as with any medicine, we want to understand both
the benefits and risks. Bacille Calmette-Guérin (BCG) vaccine is given to
children to protect against tuberculosis. BCG (re)vaccination is increasingly
being considered in adults for the protection against a variety of infections
and diseases. </p>
<p>Despite
one century since this vaccine was first used, there is a paucity of data on
the safety of BCG vaccination and revaccination in adults. Optimal management
strategies for common injection site reactions remain uncertain. </p>
<p>This
PhD project investigates the safety of revaccination, the predictors for and
the management of adverse reactions, through active safety surveillance within
an international clinical trial -‘BCG vaccination to reduce the Impact of
COVID-19 in healthcare workers’ (BRACE). </p>